ISIC Q86 · Syrian Arab Republic · 2 publishers
Healthcare in Syrian Arab Republic
386 verified figures for Syrian Arab Republic, covering 13 indicators from 2 primary sources. Every figure links to the report it came from.
Syria compared
| Measure | Syrian Arab Republic | Highest country |
|---|---|---|
| Current health expenditure (CHE) as percentage of GDP (%) | 2.71%Syrian Arab Republic · 2023 | 27.1%Tuvalu · 2023 |
| Current health expenditure (CHE) per capita (US$) | 33.3 USDSyrian Arab Republic · 2023 | 13,473.2 USDUnited States · 2023 |
| Domestic general government health expenditure as percentage of GDP (%) | 0.4%Syrian Arab Republic · 2023 | 19.7%Tuvalu · 2023 |
The short version
Key takeaways
Market size and output 3
- Current health expenditure (CHE) per capita in Syria (US$) was 33.3 USD in 2023 (WHO). WHO ↗ T1 Official
- Current health expenditure (CHE) as percentage of GDP in Syria (%) was 2.71% in 2023 (WHO). WHO ↗ T1 Official
- Domestic general government health expenditure as percentage of GDP in Syria (%) was 0.4% in 2023 (WHO). WHO ↗ T1 Official
Adoption and share 3
- DTP3 immunization coverage among 1-year-olds in Syria (%) was 60% in 2025 (WHO). WHO ↗ T1 Official
- Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds in Syria (%) was 69% in 2025 (WHO). WHO ↗ T1 Official
- Measles-containing-vaccine second-dose (MCV2) immunization coverage in Syria (%) was 62% in 2025 (WHO). WHO ↗ T1 Official
Other measures 4
- Life expectancy at birth, total in Syria (years) was 72.6 years in 2024 (World Bank). World Bank ↗ T1 Official
- Adult obesity prevalence in Syria (age-standardized, %) was 33% in 2024 (WHO). WHO ↗ T1 Official
- Adult obesity prevalence: female in Syria (age-standardized, %) was 40.1% in 2024 (WHO). WHO ↗ T1 Official
- Adult obesity prevalence: male in Syria (age-standardized, %) was 25.2% in 2024 (WHO). WHO ↗ T1 Official
The complete table
Healthcare data for Syrian Arab Republic
Every row links to its own page with the full source, verbatim quote and citation.
386 data points across 13 indicators. Each line shows the latest value; open a line for earlier periods and forecasts.
IndicatorPeriodValueSourceType
Adult obesity prevalence (age-standardized, %)+34 more202433%WHOT12024estimate→
Adult obesity prevalence: female (age-standardized, %)+34 more202440.1%WHOT12024estimate→
Adult obesity prevalence: male (age-standardized, %)+34 more202425.2%WHOT12024estimate→
Current health expenditure (CHE) as percentage of GDP (%)+23 more20232.71%WHOT12023actual→
Current health expenditure (CHE) per capita (US$)+23 more202333.3 USDWHOT12023actual→
Domestic general government health expenditure as percentage of GDP (%)+23 more20230.4%WHOT12023actual→
DTP3 immunization coverage among 1-year-olds (%)+25 more202560%WHOT12025estimate→
Life expectancy at birth, total (years)+64 more202472.6 yearsWorld BankT12024estimate→
Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%)+25 more202569%WHOT12025estimate→
Measles-containing-vaccine second-dose (MCV2) immunization coverage (%)+25 more202562%WHOT12025estimate→
NCD mortality rate (per 100,000 population)+21 more2021669 per 100,000 peopleWHOT12021estimate→
Premature NCD mortality probability (ages 30–70, %)+21 more202121.3%WHOT12021estimate→
Suicide mortality rate (per 100,000 population)+21 more20210.66 per 100,000 peopleWHOT12021estimate→
Primary documents
Sources
| Document | Publisher | Authority tier | Accessed | Locator | Data points |
|---|---|---|---|---|---|
| World Bank life expectancy at birth (total, years) Dataset | World Bank | T1 Official | 3 Oct 2026 | SP.DYN.LE00.IN: {"countryiso3code":"SYR","date":"2024","indicator.id":"SP.DYN.LE00.IN"}; SP.DYN.LE00.IN: {"countryiso3code":"SYR","date":"2023","indicator.id":"SP.DYN.LE00.IN"}; SP.DYN.LE00.IN: {"countryiso3code":"SYR","date":"2022","indicator.id":"SP.DYN.LE00.IN"} | 65 |
| WHO adult obesity prevalence (age-standardized, both sexes) Dataset | WHO | T1 Official | 2 Oct 2026 | NCD_BMI_30A: {"Dim1":"SEX_BTSX","SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2024"}; NCD_BMI_30A: {"Dim1":"SEX_BTSX","SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2023"}; NCD_BMI_30A: {"Dim1":"SEX_BTSX","SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2022"} | 35 |
| WHO adult obesity prevalence (age-standardized, female) Dataset | WHO | T1 Official | 2 Oct 2026 | NCD_BMI_30A: {"Dim1":"SEX_FMLE","SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2024"}; NCD_BMI_30A: {"Dim1":"SEX_FMLE","SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2023"}; NCD_BMI_30A: {"Dim1":"SEX_FMLE","SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2022"} | 35 |
| WHO adult obesity prevalence (age-standardized, male) Dataset | WHO | T1 Official | 2 Oct 2026 | NCD_BMI_30A: {"Dim1":"SEX_MLE","SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2024"}; NCD_BMI_30A: {"Dim1":"SEX_MLE","SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2023"}; NCD_BMI_30A: {"Dim1":"SEX_MLE","SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2022"} | 35 |
| WHO current health expenditure (CHE) as percentage of GDP Dataset | WHO | T1 Official | 2 Oct 2026 | GHED_CHEGDP_SHA2011: {"SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2023"}; GHED_CHEGDP_SHA2011: {"SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2022"}; GHED_CHEGDP_SHA2011: {"SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2021"} | 24 |
| WHO current health expenditure (CHE) per capita in US$ Dataset | WHO | T1 Official | 2 Oct 2026 | GHED_CHE_pc_US_SHA2011: {"SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2023"}; GHED_CHE_pc_US_SHA2011: {"SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2022"}; GHED_CHE_pc_US_SHA2011: {"SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2021"} | 24 |
| WHO/UNICEF DTP3 immunization coverage among 1-year-olds Dataset | WHO | T1 Official | 2 Oct 2026 | WHS4_100: {"SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2025"}; WHS4_100: {"SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2024"}; WHS4_100: {"SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2023"} | 26 |
| WHO domestic general government health expenditure as percentage of GDP Dataset | WHO | T1 Official | 2 Oct 2026 | GHED_GGHE-DGDP_SHA2011: {"SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2023"}; GHED_GGHE-DGDP_SHA2011: {"SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2022"}; GHED_GGHE-DGDP_SHA2011: {"SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2021"} | 24 |
| WHO/UNICEF MCV1 immunization coverage among 1-year-olds Dataset | WHO | T1 Official | 2 Oct 2026 | WHS8_110: {"SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2025"}; WHS8_110: {"SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2024"}; WHS8_110: {"SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2023"} | 26 |
| WHO/UNICEF MCV2 immunization coverage by recommended age Dataset | WHO | T1 Official | 2 Oct 2026 | MCV2: {"SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2025"}; MCV2: {"SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2024"}; MCV2: {"SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2023"} | 26 |
| WHO age-standardized NCD mortality rate (per 100,000 population, both sexes) Dataset | WHO | T1 Official | 3 Oct 2026 | WHS2_131: {"Dim1":"SEX_BTSX","SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2021"}; WHS2_131: {"Dim1":"SEX_BTSX","SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2020"}; WHS2_131: {"Dim1":"SEX_BTSX","SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2019"} | 22 |
| WHO probability of premature death from four main NCDs (ages 30–70, %) Dataset | WHO | T1 Official | 3 Oct 2026 | NCDMORT3070: {"Dim1":"SEX_BTSX","SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2021"}; NCDMORT3070: {"Dim1":"SEX_BTSX","SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2020"}; NCDMORT3070: {"Dim1":"SEX_BTSX","SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2019"} | 22 |
| WHO age-standardized suicide mortality rate (per 100,000 population, both sexes) Dataset | WHO | T1 Official | 3 Oct 2026 | MH_12: {"Dim1":"SEX_BTSX","SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2021"}; MH_12: {"Dim1":"SEX_BTSX","SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2020"}; MH_12: {"Dim1":"SEX_BTSX","SpatialDim":"SYR","SpatialDimType":"COUNTRY","TimeDim":"2019"} | 22 |
Report snapshots are retained internally for verification only and are never redistributed. Where a figure comes from a paywalled report, only the number published in its public summary is recorded.
All 386 collected records for Syrian Arab Republic are published as verified.
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. Each figure's own page carries APA, MLA, Chicago and BibTeX citations naming its original publisher.
StatOrigin. (2026). Healthcare in Syrian Arab Republic: statistics. Retrieved from https://statorigin.org/industries/healthcare/syrian-arab-republic